Deadline: January 7, 2027

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Offered by National Institutes of Health; applications due January 7, 2027.

Key Facts

Funder
National Institutes of Health
Award amount
Not specified by funder
Deadline
January 7, 2027
Geography
United States
Categories
Research
Status
Open

About This Grant

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, simulations, and validation using available...

Full requirements and application instructions: official listing.

Similar Open Grants

Due April 9, 2027$200K

Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)

National Institutes of Health

Due November 6, 2026$350K

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

National Institutes of Health

Due January 28, 2027

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

National Institutes of Health

Due May 8, 2027

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

National Institutes of Health

Due April 28, 2027

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

National Institutes of Health

Due May 7, 2027

Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)

National Institutes of Health

Due January 7, 2027

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

National Institutes of Health

Due January 7, 2027

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

National Institutes of Health

Due January 7, 2027

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

National Institutes of Health

Due January 7, 2027

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

National Institutes of Health

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.